首页> 美国卫生研究院文献>PLoS ONE >Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

【2h】

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

机译：肌酐清除时间随时间的变化以及接受标准剂量（300mg /天）的含有标准剂量（300mg /天）的拉米夫定抗逆转录病毒治疗的肠胃抗逆转录病毒治疗30-49Vs≥50ml/ min

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 PLoS ONE
作者
Lisa L. Ross; A. Sarah Walker; Yu Lou; Allan R. Tenorio; Diana M. Gibb; Julia Double; Charles Gilks; Cynthia C. McCoig; Paula Munderi; Godfrey Musoro; Cissy M. Kityo; Heiner Grosskurth; James Hakim; Peter N. Mugyenyi; Amy Cutrell; Teodora Perger; Mark S. Shaefer;
展开▼
作者单位

展开▼
年(卷),期 2019(14),11
年度 2019
页码 e0225199
总页数 14
原文格式 PDF
正文语种
中图分类生物学;
关键词

相似文献

外文文献

1. Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min [J] . Lisa L. Ross, A. Sarah Walker, Yu Lou, PLoS One . 2019,第11期

机译：肌酐清除时间随时间的变化和接受标准剂量（300mg /天）的含有标准剂量（300mg /天）的拉米夫定的抗逆转录病毒治疗的胃肠阳性成年人的急外不良事件的比较，基线肌酐清除率为30-49Vs≥50ml/ min
2. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy. [J] . Kremer JM, Petrillo GF, Hamilton RA The Journal of rheumatology . 1995,第1期

机译：接受标准剂量的每周甲氨蝶呤口服治疗的类风湿关节炎患者的药代动力学和肾功能：与治疗6个月后肌酐清除率和肾脏清除率显着降低有关。
3. Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance 50 mL/min: The UK Primary Care Experience [J] . Spanopoulos Dionysis, Barrett Brendan, Busse Michael, Clinical therapeutics . 2018,第8期

机译：DPP-4抑制剂的处方对成人2型糖尿病患者和肌酐清除率和GT; 50 ml / min：英国初级保健体验
4. PDB102 - THERAPY ADJUSTMENT FOLLOWING DPP-4 INHIBITOR INITIATION IN T2DM PATIENTS WITH CREATININE CLEARANCE <50 ML/MIN: A RETROSPECTIVE COHORT STUDY USING DATA FROM UK GENERAL PRACTICE [O] . D. Spanopoulos, B. Barrett, M. Busse, 2018

机译：PDB102 - 治疗调整后DPP-4抑制剂在T2DM患者中启动肌酐清除率<50毫升/分钟：使用来自英国一般实践的数据的回顾性队列研究

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min

著录项

相似文献

相关主题

期刊订阅